Search alternatives:
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), we decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), we decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
6721
-
6722
Identification of VHL as a novel E3 ubiquitin ligase for Vpx.
Published 2025“…Data are presented as mean ± standard deviation (SD) (n = 2). Statistical significance was evaluated using a two-tailed unpaired <i>t</i>-test. …”
-
6723
-
6724
Related to Fig 2.
Published 2025“…(<b>C</b>) Cell proliferation studies show a decrease in the proliferation of BT-474_RICTOR<sup>SH</sup> cells (mean ± SEM, <i>n</i> = 3) compared to BT-474_SCRAM<sup>SH</sup> cells. …”
-
6725
Average wellness for matchday, MD
Published 2025“…<div><p>Background</p><p>Exposure to match loads significantly affects physiological and psychological indicators and, consequently, players’ wellness. …”
-
6726
RICTOR silencing inhibits cell proliferation via UGCG regulation.
Published 2025“…(<b>C</b>) Cell proliferation studies show a decrease in the proliferation of MCF-7_RICTOR<sup>SH</sup> cells (mean ± SEM, <i>n</i> = 4) compared to MCF-7_SCRAM<sup>SH</sup> cells. …”
-
6727
The RehaGait® system.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
6728
Flow chart of included patients and dropouts.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
6729
Dataset of the analyzed data.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
6730
-
6731
ERI Thresholds Between Adjacent Zones.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6732
Location of the study area.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6733
Random Forest structure with cross-validation.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6734
Land use change from 1990 to 2020.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6735
Geographic data.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6736
Classification accuracy.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6737
BrdU assay in control siRNA (blue bars) and in PAX6 knockdown (red bars) limbal epithelial cells (LECs) without and after 1µM or 5µM RA incubation for 48 hours.
Published 2025“…<p>Two-way ANOVA, followed by Dunnett’s test was used. Significant p values (<0.05) are highlighted. BrdU assay shows a significantly lower proliferation rate in the PAX6 siRNA knockdown group than in control siRNA group (p < 0.001). 5µM RA treatment significantly decreased proliferation rate in controls (p = 0.025). …”
-
6738
Related to Fig 3.
Published 2025“…(<b>Q</b>) Tumor growth kinetics recorded a significantly higher growth of BT-474_ZFX<sup>OE</sup> (mean ± SEM, <i>n</i> = 5) than BT-474_VECT<sup>OE</sup> tumors. …”
-
6739
-
6740